← All trials
NCT06055582
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 11, 2022
- Primary completion
- Feb 15, 2023
- Completion date
- Mar 1, 2023
- First posted
- Sep 26, 2023
- Last posted
- Sep 26, 2023
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Diabetes Foundation, IndiaLead sponsor
- Diabetes Foundation, IndiaReponsible party - principal investigator
- Indian Council of Medical ResearchCollaborator
- Fortis Hospitals, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.